作者:Chunjian Liu、James Lin、Sidney Pitt、Rosemary F. Zhang、John S. Sack、Susan E. Kiefer、Kevin Kish、Arthur M. Doweyko、Hongjian Zhang、Punit H. Marathe、James Trzaskos、Murray Mckinnon、John H. Dodd、Joel C. Barrish、Gary L. Schieven、Katerina Leftheris
DOI:10.1016/j.bmcl.2008.02.011
日期:2008.3
SAR studies of a novel class of benzothiazole based inhibitors of p38alpha MAP kinase are described. The issue of metabolic instability associated with vicinal phenyl, benzo[d]thiazol-6-yl oxazoles/imidazoles was addressed by the replacement of the central oxazole or imidazole ring with an aminopyrazole system. The proposed binding mode of this new class of p38alpha inhibitors was confirmed by X-ray
描述了新型基于苯并噻唑的p38alpha MAP激酶抑制剂的合理设计,合成和SAR研究。与邻位苯基,苯并[d]噻唑-6-基恶唑/咪唑相关的代谢不稳定问题是通过用氨基吡唑系统取代中央恶唑或咪唑环来解决的。通过与p38alpha酶结合的代表性抑制剂(6a)的X射线晶体学研究证实了这种新型的p38alpha抑制剂的结合模式。